A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

Study Identifier
P19-568
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Recruitment Complete
Sign up for trial alerts

Study Details

Medical Condition
  • Blood Cancer - Chronic Lymphocytic Leukemia (CLL)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    This study is being done to evaluate the clinical outcomes of Chronic Lymphocytic Leukemia (CLL) participants treated with venetoclax as routine standard of care in Greece. The decision to treat with venetoclax is made by the participant's physician prior to being offered enrollment in this study.

    The objectives of this study include determining overall response rate, assessing safety information, analyzing patient profiles and disease characteristics and participant quality of life.

    Study Locations

    Location
    Status
    Location
    Henry Dunnant Hospital Center /ID# 241682
    Athens, Attica, Greece, 11526
    Status
    Not applicable
    Location
    General Hospital of Athens Gennimatas /ID# 212917
    Athens, Attica, Greece, 11527
    Status
    Not applicable
    Location
    General Hospital of Athens Laiko /ID# 212902
    Athens, Attica, Greece, 11527
    Status
    Not applicable
    Location
    General Hospital of Athens Laiko /ID# 230222
    Athens, Attica, Greece, 11527
    Status
    Not applicable
    Location
    University General Hospital Attikon /ID# 212915
    Athens, Attica, Greece, 12462
    Status
    Not applicable
    Location
    Metropolitan General /ID# 212934
    Cholargós, Attica, Greece, 15562
    Status
    Not applicable
    Showing {first} - {last} of {total} Results